rs202145480
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020800.3(IFT80):āc.1678A>Gā(p.Asn560Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000806 in 1,613,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020800.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFT80 | NM_020800.3 | c.1678A>G | p.Asn560Asp | missense_variant | 16/20 | ENST00000326448.12 | NP_065851.1 | |
TRIM59-IFT80 | NR_148401.1 | n.2386A>G | non_coding_transcript_exon_variant | 14/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFT80 | ENST00000326448.12 | c.1678A>G | p.Asn560Asp | missense_variant | 16/20 | 1 | NM_020800.3 | ENSP00000312778 | P1 | |
IFT80 | ENST00000483465.5 | c.1267A>G | p.Asn423Asp | missense_variant | 15/19 | 1 | ENSP00000418196 | |||
IFT80 | ENST00000496589.5 | c.1267A>G | p.Asn423Asp | missense_variant | 17/21 | 2 | ENSP00000420646 | |||
IFT80 | ENST00000487943.5 | n.2897A>G | non_coding_transcript_exon_variant | 16/20 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152112Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000179 AC: 45AN: 250730Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135606
GnomAD4 exome AF: 0.0000773 AC: 113AN: 1460968Hom.: 0 Cov.: 31 AF XY: 0.0000784 AC XY: 57AN XY: 726854
GnomAD4 genome AF: 0.000112 AC: 17AN: 152112Hom.: 0 Cov.: 33 AF XY: 0.000135 AC XY: 10AN XY: 74296
ClinVar
Submissions by phenotype
Asphyxiating thoracic dystrophy 2 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Feb 06, 2019 | The IFT80 c.1678A>G; p.Asn560Asp variant (rs202145480), to our knowledge, has not been described in the medical literature but is listed as a variant of unknown significance in ClinVar (Variation ID: 343967). It is observed at an overall frequency of 0.016% (46/282116 alleles) with increased frequency in the Ashkenazi Jewish population (0.35%) in the Genome Aggregation Database. The asparagine at codon 560 is moderately conserved, and computational algorithms (PolyPhen-2, SIFT) predict that this variant is tolerated. However, due to the lack of clinical and functional data regarding this variant, its clinical significance cannot be determined with certainty. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2022 | The c.1678A>G (p.N560D) alteration is located in exon 16 (coding exon 15) of the IFT80 gene. This alteration results from a A to G substitution at nucleotide position 1678, causing the asparagine (N) at amino acid position 560 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Jeune thoracic dystrophy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 29, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at